Respiratory News and Research

RSS

Breakthrough vaccine against deadly Nipah virus

A major breakthrough in the development of a highly effective vaccine against the deadly Nipah virus has been reported by a team of federal and university scientists. The results of their study, "A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge," will appear in Science Translational Medicine online.

10 Aug 2012

FDA approved drug to treat Ph- acute lymphoblastic leukemia

The U.S. Food and Drug Administration today approved Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.

10 Aug 2012

Allergies appear to lower brain tumor risk

Testing positive for immunoglobulin E, a biomarker of allergy, reduces a person’s risk for developing glioma, show study findings.

10 Aug 2012

Hydrocephalus dictates age-related SAH outcomes

Age is only predictive of poor outcome after aneurysmal subarachnoid hemorrhage because of its association with hydrocephalus, say researchers.

10 Aug 2012

ICD use contributes to decline in cardiac arrest

Implantable cardioverter defibrillator use is responsible for one-third of the decline in cardiac arrests caused by ventricular fibrillation, researchers say.

9 Aug 2012

Pre-cesarean antibiotics cut infection risk

Administering prophylactic antibiotics before women undergo cesareans significantly reduces postsurgical infection rates, show US study findings.

9 Aug 2012

Researchers urge shakeup to laparoscopic cholecystectomy timing

The tradition of delaying laparoscopic cholecystectomy after hospital admission for mild gallstone pancreatitis may be unnecessary, say the authors of a US study.

9 Aug 2012

Patient, not surgeon factors influence patient-centric outcomes after knee surgery

Patient factors are more important than anything surgeons can control during total knee replacement surgery in the prediction of patient-reported outcome measures, report UK researchers.

9 Aug 2012

Salvage surgery for oropharyngeal cancer needs due consideration

Japanese study results indicate a 5-year overall survival rate of 49% for oropharyngeal cancer patients treated with salvage surgery after initial treatment with chemoradiotherapy has failed.

9 Aug 2012

Patient cognition may affect EOL care intensity

Mild cognitive impairment in patients with advanced cancer may affect the intensity of end-of-life treatment and promote decision-making by caregivers, rather than patients, show US study results.

9 Aug 2012

Loyola to offer new radiotherapy system for cancer patients

A new radiotherapy system at Loyola University Medical Center will offer cancer patients shorter radiation treatments, with pinpoint accuracy and precision.

9 Aug 2012

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.

9 Aug 2012